Tonix Pharmaceuticals Holding (TNXP) Non-Current Assets (2010 - 2026)

Tonix Pharmaceuticals Holding has reported Non-Current Assets for 17 years, with the latest figure at $50.7 million in Q2 2026.

• On a quarterly basis, Non-Current Assets rose 15.59% year-over-year to $50.7 million in Q2 2026; TTM through Jun 2026 was $194.1 million, a 10.61% increase from a year earlier, with the FY2025 full-year figure at $48.3 million, up 10.04% from the prior year.
• Non-Current Assets was $50.7 million for Q2 2026 at Tonix Pharmaceuticals Holding, roughly flat from $50.7 million in the prior quarter.
• The five-year high for Non-Current Assets was $108.4 million in Q2 2023, with the low at $43.3 million in Q1 2025.
• Average Non-Current Assets over 5 years is $71.1 million, with a median of $60.7 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2024: Non-Current Assets surged 609.63% in 2022, then slumped 58.86% in 2024.
• Over 5 years, Non-Current Assets stood at $94.9 million in 2022, then rose by 12.41% to $106.7 million in 2023, then plunged by 58.86% to $43.9 million in 2024, then increased by 10.04% to $48.3 million in 2025, then increased by 4.89% to $50.7 million in 2026.
• The last three Non-Current Assets figures came in at $50.7 million (Q2 2026), $50.7 million (Q1 2026), and $48.3 million (Q4 2025), per Business Quant data.